Planta Medica International Open 2017; 4(S 01): S1-S202
DOI: 10.1055/s-0037-1608123
Poster Session
Georg Thieme Verlag KG Stuttgart · New York

Secondary metabolites with anti-platelet aggregation activity from the insect Tenebrio molitor

IW Park
1   College of Pharmacy, Chungnam National University, Daejeon, Korea, Republic of (South)
,
DY Kim
1   College of Pharmacy, Chungnam National University, Daejeon, Korea, Republic of (South)
,
JS Bae
2   College of Pharmacy, CMRI, Research Institute of Pharmaceutical Science, Kyungpook National University, Daegu, Korea, Republic of (South)
,
MK Na
1   College of Pharmacy, Chungnam National University, Daejeon, Korea, Republic of (South)
› Author Affiliations
Further Information

Publication History

Publication Date:
24 October 2017 (online)

 

Recently, researches for novel food and medicinal materials have focused on insect resources. Tenebrio molitor is an edible insect and recognized to have various biological properties, such as antimicrobial, anticancer, antidementia, and antihypertensive effects. The aim of this study was to identify previously unreported bioactive anti-platelet compounds from T. molitor larvae. Chemical investigation on the larvae resulted in the isolation of ten secondary metabolites. The structures of these entities were identified as cyclo(L-Val-L-Pro) (1), cyclo(L-Ala-L-Pro) (2), cyclo(L-Pro-L-Tyr) (3), cyclo(L-Phe-L-Tyr) (4), cyclo(Val-Tyr) (5), cyclo(Ala-Ile) (6), hydroxytyrosol (7), N-acetyldopamine (8), N-acetyltyramine (9), and oleracein E (10) based on spectroscopic data analysis. All the isolates were evaluated for anti-platelet aggregation properties by monitoring clotting time. Cyclo(L-Pro-L-Tyr) (3), hydroxytyrosol (7), and N-acetyltyramine (9) were shown to have platelet aggregation inhibitory activities. Collectively, these results show that compounds 3, 7, and 9 could serve as candidates and provide scaffolds for the development of new anti-platelet drugs.